Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chudnovsky

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
JCO Precision Oncology|February 17, 2022
Response of a Metastatic Breast Carcinoma With a Previously Uncharacterized ERBB2 G776V Mutation to Human Epidermal Growth Factor Receptor 2-Targeted TherapyYakov Chudnovsky, Runjun D Kumar, Alexa B Schrock, et al.
Pediatric Blood & Cancer|December 29, 2016
A case of advanced infantile myofibromatosis harboring a novel MYH10-RET fusionMark Rosenzweig, Siraj M Ali, Victor Wong, et al.
Environmental Research|August 2, 2017
Fine particulate matter and cardiovascular disease: Comparison of assessment methods for long-term exposureLaura A McGuinn, Cavin Ward-Caviness, Lucas M Neas, et al.
Clinical Lung Cancer|April 30, 2015
Detection of Crizotinib-Sensitive Lung Adenocarcinomas With MET, ALK, and ROS1 Genomic Alterations via Comprehensive Genomic ProfilingXiuning Le, Jason A Freed, Paul A VanderLaan, et al.
International Journal of Cancer|August 29, 2015
The distribution of BRAF gene fusions in solid tumors and response to targeted therapyJeffrey S Ross, Kai Wang, Juliann Chmielecki, et al.
Nature Communications|November 24, 2025
GII.17 norovirus re-emerged in the 2020s as a result of dynamic and adaptive evolutionary processesKentaro Tohma, Sonja Jacobsen, Britta Altmann, et al.
Environmental Research|July 4, 2017
Exploring pathways linking greenspace to health: Theoretical and methodological guidanceIana Markevych, Julia Schoierer, Terry Hartig, et al.
The Oncologist|February 12, 2020
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable ResponseAndge Valiakhmetova, Sergey Gorelyshev, Alexander Konovalov, et al.
ESMO Open|September 3, 2021
Erratum to 'Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial': [ESMO Open Volume 6, Issue 3, June 2021, 100101]T K Choueiri, J Larkin, S Pal, et al.
ESMO Open|April 26, 2021
Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trialT K Choueiri, J Larkin, S Pal, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
JCO Precision Oncology|February 17, 2022
Response of a Metastatic Breast Carcinoma With a Previously Uncharacterized ERBB2 G776V Mutation to Human Epidermal Growth Factor Receptor 2-Targeted TherapyYakov Chudnovsky, Runjun D Kumar, Alexa B Schrock, et al.
Pediatric Blood & Cancer|December 29, 2016
A case of advanced infantile myofibromatosis harboring a novel MYH10-RET fusionMark Rosenzweig, Siraj M Ali, Victor Wong, et al.
Environmental Research|August 2, 2017
Fine particulate matter and cardiovascular disease: Comparison of assessment methods for long-term exposureLaura A McGuinn, Cavin Ward-Caviness, Lucas M Neas, et al.
Clinical Lung Cancer|April 30, 2015
Detection of Crizotinib-Sensitive Lung Adenocarcinomas With MET, ALK, and ROS1 Genomic Alterations via Comprehensive Genomic ProfilingXiuning Le, Jason A Freed, Paul A VanderLaan, et al.
International Journal of Cancer|August 29, 2015
The distribution of BRAF gene fusions in solid tumors and response to targeted therapyJeffrey S Ross, Kai Wang, Juliann Chmielecki, et al.
Nature Communications|November 24, 2025
GII.17 norovirus re-emerged in the 2020s as a result of dynamic and adaptive evolutionary processesKentaro Tohma, Sonja Jacobsen, Britta Altmann, et al.
Environmental Research|July 4, 2017
Exploring pathways linking greenspace to health: Theoretical and methodological guidanceIana Markevych, Julia Schoierer, Terry Hartig, et al.
The Oncologist|February 12, 2020
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable ResponseAndge Valiakhmetova, Sergey Gorelyshev, Alexander Konovalov, et al.
ESMO Open|September 3, 2021
Erratum to 'Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial': [ESMO Open Volume 6, Issue 3, June 2021, 100101]T K Choueiri, J Larkin, S Pal, et al.
ESMO Open|April 26, 2021
Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trialT K Choueiri, J Larkin, S Pal, et al.
Pageof 15